荃信生物-B(02509)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02509 荃信生物-B

提前休市 12-24 12:08:24

18.210

+0.000

0.00%

最高18.820	最低17.800	成交量28.82万
今开18.210	昨收18.210	日振幅5.60%
总市值41.15亿	流通市值41.15亿	总股本2.26亿
成交额527.22万	换手率0.13%	流通股本2.26亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02509","market":"HK","secType":"STK","nameCN":"荃信生物-B","latestPrice":18.21,"timestamp":1766549304005,"preClose":18.21,"halted":0,"volume":288200,"delay":0,"floatShares":225999999,"shares":225999999,"eps":-1.696939828834222,"marketStatus":"提前休市","change":0,"latestTime":"12-24 12:08:24","open":18.21,"high":18.82,"low":17.8,"amount":5272188,"amplitude":0.056013,"askPrice":18.75,"askSize":2400,"bidPrice":18.21,"bidSize":400,"shortable":3,"etf":0,"ttmEps":-0.9582896579949928,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766971800000},"marketStatusCode":6,"adr":0,"listingDate":1710864000000,"exchange":"SEHK","adjPreClose":18.21,"openAndCloseTimeList":[[1766539800000,1766548800000]],"volumeRatio":2.858096,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02509","defaultTab":"news","newsList":[{"id":"2593412728","title":"每日卖空追踪 | 荃信生物-B 12月23日卖空量成交4200股，卖空比例为1.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593412728","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593412728?lang=zh_cn&edition=full","pubTime":"2025-12-23 16:30","pubTimestamp":1766478631,"startTime":"0","endTime":"0","summary":"荃信生物-B北京时间12月23日，跌4.46%，卖空量成交4200股，较上一交易日减少89.9%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223163438a6c51eae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223163438a6c51eae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2593412723","title":"荃信生物-B盘中异动 临近收盘股价大跌5.56%报18.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593412723","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593412723?lang=zh_cn&edition=full","pubTime":"2025-12-23 15:58","pubTimestamp":1766476715,"startTime":"0","endTime":"0","summary":"2025年12月23日临近收盘15时58分，荃信生物-B股票出现异动，股价急速跳水5.56%。截至发稿，该股报18.000港元/股，成交量25.7万股，换手率0.11%，振幅7.82%。资金方面，该股资金流入260.629万港元，流出217.207万港元。荃信生物-B股票所在的生物技术行业中，整体跌幅为1.84%。其相关个股中，药明巨诺-B、东曜药业-B、昭衍新药涨幅较大，振幅较大的相关个股有翰思艾泰-B、华仁生物-B、药捷安康-B，振幅分别为38.38%、18.07%、17.78%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223155835a6c4f50c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223155835a6c4f50c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2593936724","title":"2025年岁末，国产创新药出海热潮再起！涉及先声药业、荃信生物等","url":"https://stock-news.laohu8.com/highlight/detail?id=2593936724","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593936724?lang=zh_cn&edition=full","pubTime":"2025-12-23 09:42","pubTimestamp":1766454156,"startTime":"0","endTime":"0","summary":"2025年进入12月，国产创新药出海热潮再次掀起。如12月22日，先声药业发布公告，与Ipsen签订了独家授权许可协议，涉及其开发的抗体药物偶联物SIM0613。此外，长春高新、复星医药等多家药企均在本月宣布达成创新药授权合作。从单个企业的零星出海，到产业层面的批量突围，2025年岁末的国产创新药出海热潮，标志着中国医药创新已站在新的历史起点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223094420a46c9ab2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223094420a46c9ab2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","02509","02096","BK1574","BK1191","BK1161","06978","02142"],"gpt_icon":0},{"id":"2593177488","title":"港股异动 | 荃信生物-B(02509)涨超4% 双抗新药QX027N授权出海 可获最高7亿美元付款","url":"https://stock-news.laohu8.com/highlight/detail?id=2593177488","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593177488?lang=zh_cn&edition=full","pubTime":"2025-12-22 10:16","pubTimestamp":1766369806,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，荃信生物-B涨超4%，截至发稿，涨4.36%，报19.61港元，成交额309.57万港元。消息面上，荃信生物今早宣布，12月19日，荃信生物与Windward Bio附属公司LE2025 Therapeutics AG就公司自主研发的QX027N达成授权合作。作为回报，荃信生物将有权收取最高7亿美元的付款，包括首付款、Windward Bio的股权、开发及商业里程碑付款，此外，公司还有权根据QX027N在许可地区的销售净额收取分级特许权使用费。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384236.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动 | 荃信生物-B(02509)涨超4% 双抗新药QX027N授权出海 可获最高7亿美元付款","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2593067179","title":"荃信生物-B(02509)与Windward Bio附属公司就QX027N的开发及商业化签订许可及合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2593067179","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593067179?lang=zh_cn&edition=full","pubTime":"2025-12-22 08:18","pubTimestamp":1766362723,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B 发布公告，于2025年12月19日，公司与Windward Bio Group AG的附属公司LE2025 Therapeutics AG订立许可及合作协议。该协议授予LE2025在全球范围内开发及商业化QX027N的独家权利。作为回报，公司或其指定附属公司将有权收取总额高达7亿美元的付款，包括首付款、Windward Bio的股权、开发及商业里程碑付款，以及根据QX027N在许可地区的销售净额收取分级特许权使用费。QX027N是公司自主研发的长效抗TSLPxIL-13双特异性抗体。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384170.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"1167581878","title":"荃信生物-B - 集团将获得最高达7亿美元的付款，包括预付付款等","url":"https://stock-news.laohu8.com/highlight/detail?id=1167581878","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167581878?lang=zh_cn&edition=full","pubTime":"2025-12-22 08:10","pubTimestamp":1766362209,"startTime":"0","endTime":"0","summary":"荃信生物-B - 集团将获得最高达7亿美元的付款，包括预付付款等","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"gpt_icon":0},{"id":"1173277110","title":"荃信生物-B - Le2025获得全球独家开发QX027n的权利，但不包括中国大陆及其他地区","url":"https://stock-news.laohu8.com/highlight/detail?id=1173277110","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173277110?lang=zh_cn&edition=full","pubTime":"2025-12-22 08:10","pubTimestamp":1766362208,"startTime":"0","endTime":"0","summary":"荃信生物-B - Le2025获得全球独家开发QX027n的权利，但不包括中国大陆及其他地区。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2592195655","title":"每日卖空追踪 | 荃信生物-B 12月19日卖空量成交2600股，卖空比例为2.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592195655","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592195655?lang=zh_cn&edition=full","pubTime":"2025-12-19 16:30","pubTimestamp":1766133030,"startTime":"0","endTime":"0","summary":"荃信生物-B北京时间12月19日，涨1.95%，卖空量成交2600股，较上一交易日减少31.58%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219163515a6b645f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219163515a6b645f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2592291761","title":"每日卖空追踪 | 荃信生物-B 12月17日卖空量成交7200股，卖空比例为5.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592291761","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592291761?lang=zh_cn&edition=full","pubTime":"2025-12-17 16:30","pubTimestamp":1765960230,"startTime":"0","endTime":"0","summary":"荃信生物-B北京时间12月17日，涨0.27%，卖空量成交7200股，较上一交易日减少7.69%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217163449a456135b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217163449a456135b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2591676359","title":"每日卖空追踪 | 荃信生物-B 12月15日卖空量成交3200股，卖空比例为1.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591676359","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591676359?lang=zh_cn&edition=full","pubTime":"2025-12-15 16:30","pubTimestamp":1765787430,"startTime":"0","endTime":"0","summary":"荃信生物-B北京时间12月15日，跌7.16%，卖空量成交3200股，较上一交易日减少33.33%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215163500a6a45842&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215163500a6a45842&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2590598728","title":"荃信生物-B(02509.HK)再涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590598728","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590598728?lang=zh_cn&edition=full","pubTime":"2025-12-11 15:48","pubTimestamp":1765439282,"startTime":"0","endTime":"0","summary":"每经AI快讯，荃信生物-B(02509.HK)再涨超3%，截至发稿涨3.26%，报20.9港元，成交额306.19万港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512113588839439.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512113588839439.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2590275560","title":"港股异动 | 荃信生物-B(02509)再涨超3% 双抗矩阵布局在海外正式迈入临床阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2590275560","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590275560?lang=zh_cn&edition=full","pubTime":"2025-12-11 15:29","pubTimestamp":1765438197,"startTime":"0","endTime":"0","summary":"消息面上，荃信生物宣布，12月8日，公司收到合作伙伴Caldera Therapeutics, Inc支付的500万美元里程碑付款，此付款是基于QX030N/CLD-423获得人类研究伦理委员会I期临床试验伦理许可而触发的。据悉，公司自主研发的双抗QX030N/CLD-423于澳大利亚通过HREC审批，计划于2026年初启动临床试验。本次许可标志着公司的双抗矩阵布局在海外正式迈入临床阶段，将进一步强化公司在自免及过敏疾病领域的领先地位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380329.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2590598846","title":"每日卖空追踪 | 荃信生物-B 12月10日卖空量成交1.14万股，卖空比例为4.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590598846","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590598846?lang=zh_cn&edition=full","pubTime":"2025-12-10 16:30","pubTimestamp":1765355431,"startTime":"0","endTime":"0","summary":"荃信生物-B北京时间12月10日，涨0.6%，卖空量成交1.14万股，较上一交易日减少34.48%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121016345795353d58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121016345795353d58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2590982371","title":"港股荃信生物-B涨近4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590982371","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590982371?lang=zh_cn&edition=full","pubTime":"2025-12-10 10:23","pubTimestamp":1765333414,"startTime":"0","endTime":"0","summary":"每经AI快讯，荃信生物-B(02509.HK)涨近4%，截至发稿涨3.98%，报20.92港元，成交额167.04万港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512103587474051.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512103587474051.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2590534839","title":"荃信生物-B(02509)：QX030N于澳大利亚的I期临床试验获得人类研究伦理委员会许可及收到里程碑付款","url":"https://stock-news.laohu8.com/highlight/detail?id=2590534839","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590534839?lang=zh_cn&edition=full","pubTime":"2025-12-09 19:18","pubTimestamp":1765279102,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B 公布，于2025年12月8日，公司收到合作伙伴Caldera Therapeutics, Inc.支付的500万美元里程碑付款，该付款乃基于QX030N/CLD-423*获得人类研究伦理委员会I期临床试验伦理许可而触发。近日，公司自主研发的双抗QX030N/CLD-423于澳大利亚通过HREC审批，计划于2026年初启动临床试验。据悉，公司与Caldera于2025年4月23日签署对外授权协议，Caldera获得QX030N/CLD-423的全球独家开发和商业化权利。截至2025年12月8日，公司已获得预付款及里程碑款共计1500万美元，以及Caldera一定比例的股权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1379484.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2590896392","title":"荃信生物-B12月08日遭主力抛售60.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2590896392","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590896392?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:15","pubTimestamp":1765181758,"startTime":"0","endTime":"0","summary":"12月08日, 荃信生物-B股价跌3.72%，报收20.18元，成交金额462.9万元，换手率0.10%，振幅4.58%，量比0.98。荃信生物-B今日主力资金净流出60.5万元，上一交易日主力净流出28.5万元。该股近5个交易日下跌7.09%，主力资金累计净流入66.4万元；近20日主力资金累计净流入144.5万元，其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208162147a72aa71e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208162147a72aa71e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2589381614","title":"荃信生物-B12月05日主力净流出28.5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2589381614","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589381614?lang=zh_cn&edition=full","pubTime":"2025-12-05 16:15","pubTimestamp":1764922542,"startTime":"0","endTime":"0","summary":"12月05日, 荃信生物-B股价跌0.76%，报收20.96元，成交金额522.8万元，换手率0.11%，振幅10.70%，量比1.18。荃信生物-B今日主力资金净流出28.5万元，上一交易日主力净流出0万元。该股近5个交易日下跌6.93%，主力资金累计净流入127.0万元；近20日主力资金累计净流入142.7万元，其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205161908979178d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205161908979178d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2588987002","title":"每日卖空追踪 | 荃信生物-B 12月04日卖空量成交2600股，卖空比例为1.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588987002","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588987002?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:30","pubTimestamp":1764837032,"startTime":"0","endTime":"0","summary":"荃信生物-B北京时间12月04日，涨2.13%，卖空量成交2600股，较上一交易日减少59.38%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163510978f8851&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163510978f8851&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2588073803","title":"【读财报】港股11月回购透视：合计回购超117亿港元 德康农牧、粉笔等年内首度回购","url":"https://stock-news.laohu8.com/highlight/detail?id=2588073803","media":"面包财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588073803?lang=zh_cn&edition=full","pubTime":"2025-12-04 07:30","pubTimestamp":1764804600,"startTime":"0","endTime":"0","summary":"港股上市公司11月回购总额117.42亿港元根据信披数据，2025年11月港股共有99家上市公司发起回购，累计回购7.12亿股，回购金额合计达117.42亿港元，较去年同期的206.29亿港元下降43.08%。此外，中国飞鹤、德康农牧、粉笔等公司于11月首度进行年内回购或明显加大回购力度。2025年前11月，小米集团合计回购30.38亿港元。11月，德康农牧进行年内首次港股回购，金额为5906.38万港元，回购数量为79.76万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204073045a72259e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204073045a72259e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01810","02586","03888","01931","01919","02419","06186","09886","02509","02469"],"gpt_icon":0},{"id":"2588720156","title":"荃信生物-B(02509)12月1日斥资196.12万港元回购9万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2588720156","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588720156?lang=zh_cn&edition=full","pubTime":"2025-12-01 21:04","pubTimestamp":1764594275,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B(02509)发布公告，该公司于2025年12月1日斥资196.12万港元回购9万股股份，每股回购价格为21.58-22港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1376203.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02509","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.qyuns.net","stockEarnings":[{"period":"1week","weight":-0.0065},{"period":"1month","weight":-0.0895},{"period":"3month","weight":-0.3823},{"period":"6month","weight":0.1965},{"period":"1year","weight":1.4608},{"period":"ytd","weight":1.4675}],"compareEarnings":[{"period":"1week","weight":0.0213},{"period":"1month","weight":0.022},{"period":"3month","weight":-0.0281},{"period":"6month","weight":0.0596},{"period":"1year","weight":0.2963},{"period":"ytd","weight":0.2849}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"江苏荃信生物医药股份有限公司是一家主要从事生物制药的中国公司。该公司主要从事自身免疫及过敏性疾病生物疗法的生物科技研发。该公司业务主要涵盖四大疾病领域，包括皮肤、风湿、呼吸道及消化道疾病。该公司正在研发的项目有8个，目标适应症包括银屑病、特应性皮炎、类风湿性关节炎、炎症性肠病、哮喘等。该公司核心产品有QX002N和QX005N。","exchange":"SEHK","name":"荃信生物-B","nameEN":"QYUNS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"荃信生物-B(02509)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供荃信生物-B(02509)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"荃信生物-B,02509,荃信生物-B股票,荃信生物-B股票老虎,荃信生物-B股票老虎国际,荃信生物-B行情,荃信生物-B股票行情,荃信生物-B股价,荃信生物-B股市,荃信生物-B股票价格,荃信生物-B股票交易,荃信生物-B股票购买,荃信生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"荃信生物-B(02509)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供荃信生物-B(02509)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}